Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli

FEMS Microbiology Letters

Volumn 303, Issue 1, 2010, Pages 33-40

  Ma, Chao ^a,b   Sim, Shuzhen ^a   Shi, Wanliang ^a   Du, Lijun ^b   Xing, Dongming ^b   Zhang, Ying ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Antibiotic persisters; Energy metabolism; Escherichia coli; SucB; UbiF

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; GENTAMICIN; KANAMYCIN; NORFLOXACIN; TETRACYCLINE; TRIMETHOPRIM; ACID; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MIXED FUNCTION OXIDASE; OXOGLUTARATE DEHYDROGENASE; SUCB PROTEIN, E COLI; UBIF PROTEIN, E COLI;

ACIDITY; ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM MUTANT; CONTROLLED STUDY; CULTURE MEDIUM; DELETION MUTANT; ENERGY METABOLISM; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATIVE STRESS; PH; PRIORITY JOURNAL; STRESS; SUCB GENE; SURVIVAL; UBIF GENE; DRUG EFFECTS; GENE DELETION; GENETIC COMPLEMENTATION; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ESCHERICHIA COLI;

ACIDS; AMPICILLIN; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE DELETION; GENETIC COMPLEMENTATION TEST; KETOGLUTARATE DEHYDROGENASE COMPLEX; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MIXED FUNCTION OXYGENASES; OXIDATIVE STRESS; STRESS, PHYSIOLOGICAL;

EID: 74349090538     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2009.01857.x     Document Type: Article

References (25)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA Struhl K (1987) Current Protocols in Molecular Biology. John Wiley & Sons, New York.
2. Baba T, Ara T, Hasegawa M et al 2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2.
3. Balaban NQ, Merrin J, Chait R, Kowalik L Leibler S (2004) Bacterial persistence as a phenotypic switch. Science 305 : 1622 1625.
4. Bigger JW (1944) Treatment of staphylococcal infections with penicillin. Lancet 244 : 497 500.
5. Black DS, Irwin B Moyed HS (1994) Autoregulation of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis. J Bacteriol 176 : 4081 4091.
6. Bryk R, Lima CD, Erdjument-Bromage H, Tempst P Nathan C (2002) Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science 295 : 1073 1077.
7. Hansen S, Lewis K Vulic M (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Ch 52 : 2718 2726.
8. Hobby GL, Meyer K Chaffee E (1942) Observations on the mechanism of action of penicillin. P Soc Exp Biol NY 50 : 281 285.
9. Keren I, Shah D, Spoering A, Kaldalu N Lewis K (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186 : 8172 8180.
10. Korch SB Hill TM (2006) Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J Bacteriol 188 : 3826 3836.
11. Korch SB, Henderson TA Hill TM (2003) Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol 50 : 1199 1213.
12. Kwon O, Kotsakis A Meganathan R (2000) Ubiquinone (coenzyme Q) biosynthesis in Escherichia coli: identification of the ubiF gene. FEMS Microbiol Lett 186 : 157 161.
13. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5 : 48 56.
14. Li Y Zhang Y (2007) PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Ch 51 : 2092 2099.
15. Magnuson RD (2007) Hypothetical functions of toxin-antitoxin systems. J Bacteriol 189 : 6089 6092.
16. McDermott W (1958) Microbial persistence. Yale J Biol Med 30 : 257 291.
17. Moat AG Foster JW (1995) Microbial Physiology. Wiley-Liss, New York.
18. Sat B, Hazan R, Fisher T, Khaner H, Glaser G Engelberg-Kulka H (2001) Programmed cell death in Escherichia coli: some antibiotics can trigger mazEF lethality. J Bacteriol 183 : 2041 2045.
19. Spoering AL, Vulic M Lewis K (2006) GlpD and PlsB participate in persister cell formation in Escherichia coli. J Bacteriol 188 : 5136 5144.
20. Steed PM Wanner BL (1993) Use of the rep technique for allele replacement to construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role for the PhoU protein in the phosphate regulon. J Bacteriol 175 : 6797 6809.
21. Stewart PS (2002) Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292 : 107 113.
22. Vazquez-Laslop N, Lee H Neyfakh AA (2006) Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol 188 : 3494 3497.
23. Zhang Y (2004) Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 9 : 1136 1156.
24. Zhang Y (2005) The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol 45 : 529 564.
25. Zhang Y (2007) Advances in the treatment of tuberculosis. Clin Pharmacol Ther 82 : 595 600.